Lombardi Comprehensive Cancer Center
Director, Biologic Therapy and Cutaneous Oncology Programs
Beth Israel Deaconess Medical Center
Leader, Kidney Cancer Program
Dana-Farber Harvard Cancer Center
Professor of Medicine, Medical Oncology
Director, Prostate and GU Medical Oncology
Director, Prostate Cancer Translational Research Group
Yale Cancer Center
New Haven, Connecticut
Department of Medicine and Hematology-Oncology
University of California, Los Angeles
Los Angeles, California
Professor of Medicine
Price Chair of Thoracic Translational Oncology
Director of Thoracic Oncology
Director of Immuno-Oncology
Columbia University Medical Center
New York, New York
Associate Professor of Medicine, Oncology
Department of Medicine/Oncology
Senior Clinical Editor
Editorial Director, Hematology/Oncology
This program is intended for physicians and other healthcare professionals who provide care for patients with cancer.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This program has been made available online.
Participation in this self-study activity should be completed in approximately 2.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from August 25, 2015, through August 24, 2016:
1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.
In this slideset from Clinical Care Options, experts provide insights on emerging CAR T-cell strategies for myeloma.
In this slideset from Clinical Care Options, experts provide insights into the optimal management of toxicities associated with CAR T-cell therapy.
In this slideset from Clinical Care Options, experts provide insights on the optimal use of CAR T-cell therapy for lymphomas.
In this slideset from Clinical Care Options, experts provide insights on the optimal use of CAR T-cell therapy for ALL.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.